Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Patients with type 1 diabetes who do aerobic exercise often experience a drop in blood glucose concentration that can result in hypoglycemia. Current approaches to prevent exercise-induced hypoglycemia include reduction in insulin dose or ingestion of carbohydrates, but these strategies may still result in hypoglycemia or hyperglycemia. We sought to determine whether mini-dose glucagon (MDG) given subcutaneously before exercise could prevent subsequent glucose lowering and to compare the glycemic response to current approaches for mitigating exercise-associated hypoglycemia. RESEARCH DESIGN AND METHODS: We conducted a four-session, randomized crossover trial involving 15 adults with type 1 diabetes treated with continuous subcutaneous insulin infusion who exercised fasting in the morning at ∼55% VO2max for 45 min under conditions of no intervention (control), 50% basal insulin reduction, 40-g oral glucose tablets, or 150-μg subcutaneous glucagon (MDG). RESULTS: During exercise and early recovery from exercise, plasma glucose increased slightly with MDG compared with a decrease with control and insulin reduction and a greater increase with glucose tablets (P < 0.001). Insulin levels were not different among sessions, whereas glucagon increased with MDG administration (P < 0.001). Hypoglycemia (plasma glucose <70 mg/dL) was experienced by six subjects during control, five subjects during insulin reduction, and none with glucose tablets or MDG; five subjects experienced hyperglycemia (plasma glucose ≥250 mg/dL) with glucose tablets and one with MDG. CONCLUSIONS: MDG may be more effective than insulin reduction for preventing exercise-induced hypoglycemia and may result in less postintervention hyperglycemia than ingestion of carbohydrate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Three mg of intranasal glucagon (1 mg glucagon per 10 mg dry powder) appears to have maximal effect.1231–1235”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1234]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physical activity/exercise and diabetes: A position statement of the American Diabetes Association
Colberg, S. R., Sigal, R. J., Yardley, J. E., Riddell, M. C., Dunstan, D. W., Dempsey, P. C., Horton, E. S., Castorino, K., & Tate, D. F. (2016) · Diabetes Care · doi:10.2337/dc16-1728 · Cited by 2,991 · cited 1×
“Accordingly, current guidelines recommend that all adults with type 1 diabetes engage in 150 min or more of moderate-to-vigorous intensity physical activity spread out over at least 3 days weekly (2).”
BackgroundSelf-citationExercise management in type 1 diabetes: a consensus statement
Riddell, M. C., Gallen, I. W., Smart, C. E., Taplin, C. E., Adolfsson, P., Lumb, A. N., Kowalski, A., Rabasa-Lhoret, R., McCrimmon, R. J., Hume, C., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30014-1 · Cited by 903 · cited 2×
“0 g of carbohydrate per minute of aerobic exercise depending on the timing of the exercise relative to the last insulin administration (23).”
BackgroundSelf-citationBarriers to Physical Activity Among Patients With Type 1 Diabetes
Brazeau, A.-S., Rabasa-Lhoret, R., Strychar, I., & Mircescu, H. (2008) · Diabetes Care · doi:10.2337/dc08-0720 · Cited by 595
The T1D exchange clinic registry
Beck, R. W., Tamborlane, W. V., Bergenstal, R. M., Miller, K. M., DuBose, S. N., Hall, C. A., & for the T1D Exchange Clinic Network (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1561 · Cited by 456
Self-citationAgiostratidou, G., Anhalt, H., Ball, D., Blonde, L., Gourgari, E., Harriman, K. N., Kowalski, A. J., Madden, P., McAuliffe-Fogarty, A. H., McElwee-Malloy, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1624 · Cited by 397
Bohn, B., Herbst, A., Pfeifer, M., Krakow, D., Zimny, S., Kopp, F., Melmer, A., Steinacker, J. M., & Holl, R. W. (2015) · Diabetes Care · doi:10.2337/dc15-0030 · Cited by 321 · cited 2×
“the majority of patients with type 1 diabetesare sedentary, exercising less than 30 min a day, and most now meet the criteria forbeingoverweightorobese (1).”
Backgroundthe Diabetes Research in Children Network (DirecNet) Study Group (2006) · Diabetes Care · doi:10.2337/dc06-0495 · Cited by 217
Self-citationLascar, N., Kennedy, A., Hancock, B., Jenkins, D., Andrews, R. C., Greenfield, S., & Narendran, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108019 · Cited by 183
Galassetti, P. R., Tate, D. B., Neill, R. A., Morrey, S., Wasserman, D. H., & Davis, S. N. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1761 · Cited by 151
Gómez, A. M., Giraldo, C. M. G., Aschner, P. J., Veloza, A., Múñoz, Ó., Rubio, C., & Vallejo, S. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814566233 · Cited by 139
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Exercise in adults with type 1 diabetes mellitus
Riddell, M. C., & Peters, A. L. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00756-6 · Cited by 144
Self-citationThe competitive athlete with type 1 diabetes
Riddell, M. C., Scott, S. N., Fournier, P. A., Colberg, S. R., Gallen, I. W., Moser, O., Stettler, C., Yardley, J. E., Zaharieva, D. P., Adolfsson, P., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05183-8 · Cited by 101
Self-citationRickels, M. R. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14214 · Cited by 71
Self-citationExercise‐induced hypoglycaemia in type 1 diabetes
Cockcroft, E., Narendran, P., & Andrews, R. C. (2019) · Experimental Physiology · doi:10.1113/ep088219 · Cited by 80
“reduces the risk of hypoglycaemia without increased glucose postexercise (Rickels et al., 2018) Avoidance of alcohol • Alcohol should be avoided on days when exercise is done because it increases the risk of hypoglycaemia (Richardson et al.”
BackgroundInfluential
Metadata
- Authors
- Rickels, M. R., DuBose, S. N., Toschi, E., Beck, R. W., Verdejo, A. S., Wolpert, H., Cummins, M. J., Newswanger, B., Riddell, M. C., T1D Exchange Mini-Dose Glucagon Exercise Study Group, Rickels, M., Peleckis, A., Evangelisti, M., Dalton-Bakes, C., Fuller, C., Toschi, E., Wolpsert, H., Middelbeek, R., Cherng Jye, L. S., Shahar, J., Slyne, C., Edwards, S., Castillo, A. A., DuBose, S. N., Beck, R. W., Verdejo, A. S., Cummins, M., Newswanger, B., & Prestrelski, S.
- Affiliations
- Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
- Joslin Diabetes Center (US)
- Xeris Pharmaceuticals, Inc., Austin, TX
- York University (CA)
- Corresponding author
- T1D Exchange Mini-Dose Glucagon Exercise Study Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-05-18
- Volume
- 41
- Issue
- 9
- Pages
- 1909-1916
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC6463733
- OpenAlex
- W2803450541
- Cited by
- 79
- References
- 25
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 4 · 2023: 9 · 2022: 14 · 2021: 9 · 2020: 10 · 2019: 16 · 2018: 4
- FWCI
- 7.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leona M. and Harry B. Helmsley Charitable Trust
- U.S. Public Health Service (UL1-TR-001878, P30-DK-19525)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, exercise-induced hypoglycemia, glucagon, insulin pump therapy, hyperglycemia
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Dose-Response Relationship, Drug, Fasting, Female, Glucagon, Glucose, Humans, Hypoglycemia, Insulin, Insulin Infusion Systems, Male, Exercise, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes. https://app.cochat.ai/papers/10.2337/dc18-0051
- The paper
- Rickels, M. R., DuBose, S. N., Toschi, E., Beck, R. W., Verdejo, A. S., Wolpert, H., Cummins, M. J., Newswanger, B., Riddell, M. C., T1D Exchange Mini-Dose Glucagon Exercise Study Group, Rickels, M., Peleckis, A., Evangelisti, M., Dalton-Bakes, C., Fuller, C., Toschi, E., Wolpsert, H., Middelbeek, R., Cherng Jye, L. S., . . . Prestrelski, S. (2018). Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes. Diabetes Care. https://doi.org/10.2337/dc18-0051
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.